Results 11 to 20 of about 3,863,870 (310)

Clients’ experiences on North America’s first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study

BMC Health Services Research, 2023
Background To support public health measures during the COVID-19 pandemic, oral opioid agonist treatment (OAT) take-home doses were expanded in Western countries with positive results. Injectable OAT (iOAT) take-home doses were previously not an eligible
Eugenia Oviedo-Joekes, Sophia Dobischok, José Carvajal, Scott MacDonald, Cheryl McDermid, Piotr Klakowicz, Scott Harrison, Julie LaJeunesse, Nancy Chow, Murray Brown, Sam Gill, Martin Schechter   +11 more
doaj   +1 more source

A cross-sectional survey of activities to support mental wellness during the COVID-19 pandemic

Journal of Affective Disorders Reports, 2021
Background: During the COVID-19 pandemic, public health restrictions such as social distancing, isolation and self-quarantine have been implemented for several months.
Aanchel Gupta, Joseph H. Puyat, Harmanpreet Ranote, Fidel Vila-Rodriguez, Arminee Kazanjian   +4 more
doaj   +1 more source

Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report

Harm Reduction Journal, 2021
Background For people with opioid use disorder who are not responding to oral opioid agonist treatment, evidence supports the effectiveness of injectable opioid agonist treatment with injectable hydromorphone (an opioid analgesic) and diacetylmorphine ...
Heather Palis, Scott MacDonald, Jennifer Jun, Eugenia Oviedo-Joekes   +3 more
doaj   +1 more source

Building capacity for implementation—the KT Challenge

Implementation Science Communications, 2021
Background The KT Challenge program supports health care professionals to effectively implement evidence-based practices. Unlike other knowledge translation (KT) programs, this program is grounded in capacity building, focuses on health care ...
Agnes T. Black, Marla Steinberg, Amanda E. Chisholm, Kristi Coldwell, Alison M. Hoens, Jiak Chin Koh, Allana LeBlanc, Martha Mackay, Amy Salmon, M. Elizabeth Snow   +9 more
doaj   +1 more source

The self-care for people initiative: the outcome evaluation. [PDF]

, 2012
To determine the effects of a community-based training programme in self-care on the lay ...
Bagnall, A, Forshaw, M, Marchant, P, South, J, Spoor, C, White, A, Witty, K   +6 more
core   +1 more source

Men’s and women’s response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder

Substance Abuse Treatment, Prevention, and Policy, 2017
Background To test whether there are gender differences in treatment outcomes among patients receiving injectable opioids for the treatment of long-term opioid-dependence.
Heather Palis, Kirsten Marchand, Daphne Guh, Suzanne Brissette, Kurt Lock, Scott MacDonald, Scott Harrison, Aslam H. Anis, Michael Krausz, David C. Marsh, Martin T. Schechter, Eugenia Oviedo-Joekes   +11 more
doaj   +1 more source

Examining Stakeholder Perspectives: Process, Performance and Progress of the Age-Friendly Taiwan Program. [PDF]

, 2019
Since Taiwans age-friendly city (AFC) program was launched in 2012, the central government has provided various resources to the countrys 22 local authorities, including budgetary support, policy advocacy, and consultation from a team of experts.
Hsu, Yu-Chang, Kuo, Hsien-Wen, Lin, Li-Ju, SCHARLACH, Andrew E.   +3 more
core   +1 more source

Co-production of randomized clinical trials with patients: a case study in autologous hematopoietic stem cell transplant for patients with scleroderma

Trials, 2021
Background Increasingly, it is argued that clinical trials struggle to recruit participants because they do not respond to key questions or study treatments that patients will be willing or able to use.
Magda Aguiar, Tracey-Lea Laba, Sarah Munro, Tiasha Burch, Jennifer Beckett, K. Julia Kaal, Nick Bansback, Marie Hudson, Mark Harrison   +8 more
doaj   +1 more source

Treatment Discontinuation and Clinical Events in Type 2 Diabetes Patients Treated with Dipeptidyl Peptidase-4 Inhibitors or NPH Insulin as Third-Line Therapy

Journal of Diabetes Research, 2018
Objective. To compare dipeptidyl peptidase-4 (DPP-4) inhibitors with neutral protamine Hagedorn (NPH) insulin, in terms of effectiveness and safety for the management of patients with type 2 diabetes mellitus (DM2) not controlled on metformin and ...
Cristiano S. Moura, Zale B. Rosenberg, Michal Abrahamowicz, Sasha Bernatsky, Hassan Behlouli, Louise Pilote   +5 more
doaj   +1 more source

Access to reperfusion therapy and mortality outcomes in patients with ST-segment elevation myocardial infarction under universal health coverage in Thailand

BMC Cardiovascular Disorders, 2020
Background Evidence on access to reperfusion therapy for patients with ST-segment elevation myocardial infarction (STEMI) and associated mortality in developing countries is scarce.
Chulaporn Limwattananon, Jiraphan Jaratpatthararoj, Jutatip Thungthong, Phumtham Limwattananon, Amnat Kitkhuandee   +4 more
doaj   +1 more source